It is worth noting that unlike traditional chemotherapy, which kills both cancerous and healthy cells, KMT and KDM inhibitors directly affect molecular processes associated with cancer, which can lead to more targeted and effective breast cancer therapy. The gene discussed is CAMKMT; the disease is breast carcinoma.